News

Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...
Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and PBMI Innovator Award winner, is calling for a PBM industry focus on making pharmacy experiences more seamless while continuing to ...
As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...
While competitors continue to struggle with healthcare costs, Aetna and CVS are celebrating an 8.4% increase in ...
The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...
CVS Health raised its full-year profit forecast after exceeding Wall Street quarterly earnings estimates on Thursday, as ...
Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.
California’s health care purchaser expects to save $600 million over the five-year contract with CVS Caremark.
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...